Clinical Trials Sponsored by Roger Goldstein

Total 613 results

University of Michigan Rogel Cancer Center
Phase One Foundation

Completed

Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma

Glioblastoma Multiforme | Malignant Glioma

United States
University of Michigan Rogel Cancer Center
University of Washington

Completed

A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC

Non-small Cell Lung Cancer

United States
University of Michigan
University of Michigan Rogel Cancer Center

Completed

Acupressure for Post-Treatment Cancer Fatigue

Fatigue

United States
University of Michigan Rogel Cancer Center
Hoffmann-La Roche

Terminated

Radiation Therapy With Capecitabine in Rectal Cancer

Rectal Cancer

United States
Gaia AG
University Hospital Schleswig-Holstein; Philipps Universität Marburg

Recruiting

Effectiveness of a Digital Health Application for Subacute and Chronic Back Pain (Relevis) (APRICOT)

Back Pain

Germany
University Hospital Schleswig-Holstein
SocraMetrics GmbH; Avextra Pharma GmbH

Not yet recruiting

Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO)

Quality of Life | Palliative Care | Medical Oncology | Cannabinoids

Germany
Gaia AG
University Hospital Schleswig-Holstein; University Hospital Freiburg

Completed

Effectiveness of a Digital Health Application for People With Insomnia Disorder (Somnovia)

Insomnia Disorder

Germany
University Hospital Schleswig-Holstein
Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia

Leukemia

Israel, Germany, Italy, Australia, Austria, Czechia, Switzerland
University Hospital Schleswig-Holstein
Medical Clinic III; Dezernat Apotheke

Completed

Determining Drug Levels of Beta-lactam Antibiotics in Severe Burned Patients (MSBV)

Intensive Care | Antibiotics | Severe Burn

Germany
University of Michigan Rogel Cancer Center
Bristol-Myers Squibb

Completed

The SMART CART Study: Health Information Technology

Leukemia, Acute | Leukemia, Lymphoblastic

United States
University of Michigan Rogel Cancer Center
Bristol-Myers Squibb

Completed

Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma

United States
University of Michigan Rogel Cancer Center
St. Baldrick's Foundation

Terminated

Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients

Cancer | Depression, Anxiety

United States
University of Michigan
University of Michigan Rogel Cancer Center

Completed

Fatigue Reduction Diet (FRD)

Chronic Fatigue

United States
University of Michigan Rogel Cancer Center
Novartis; Aventis Pharmaceuticals

Completed

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Hormone-Refractory Prostate Cancer

United States
Pavan Reddy, MD

Completed

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

Graft vs Host Disease | Hematologic Malignancies

United States
University of Michigan Rogel Cancer Center
University of Michigan

Terminated

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Metastatic Colorectal Cancer

United States
University of Michigan Rogel Cancer Center
Cancer Support Community

Terminated

Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program

Cancer

United States
University of Michigan Rogel Cancer Center
Unity Health Toronto

Completed

Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy

Stomach Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Gastrointestinal Cancer

United States
Sung Choi, M.D.

Completed

Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat

Quality of Life | Graft-vs-Host Disease

United States
University of Michigan Rogel Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma

Neuroblastoma

United States
University of Michigan Rogel Cancer Center
GlaxoSmithKline; Gilead Sciences

Withdrawn

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

Lymphoma

United States
Rhone-Poulenc Rorer

Completed

Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients

HIV Infections | Cryptosporidiosis

United States
Washington University School of Medicine
McDonnell Center; Paula and Roger Riney Blood Cancer Research

Terminated

Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T Therapy

Neurotoxicity

United States
Wake Network, Inc.
Professor Roger Gibson Section of Psychiatry Faculty of Medical Sciences UWI

Withdrawn

Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults

Anxiety and Depression

Jamaica
howard safran
The Miriam Hospital; Rhode Island Hospital; Roger Williams Medical Center

Terminated

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Gastric Cancer | Gastrooesophageal Cancer | Esophageal

United States
Roger Williams Medical Center
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Bioengineered Skin and Wound Healing

Leg Ulcers

United States
Jena University Hospital
University Hospital Schleswig-Holstein; Klinikum Stuttgart

Not yet recruiting

Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer (ultraHART)

Quality of Life | Prostate Cancer | Adaptive Radiotherapy

Germany
Gaia AG
University Hospital Schleswig-Holstein; Universität Duisburg-Essen

Recruiting

Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex) (LAMONT)

Multiple Sclerosis

Germany
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Recruiting

Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer

Thyroid Cancer

United States
University of Michigan Rogel Cancer Center
Janssen Scientific Affairs, LLC

Recruiting

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS)

Prostate Cancer

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Prostate Cancer

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion

Liver Cancer

United States
University of Michigan Rogel Cancer Center
Janssen Scientific Affairs, LLC

Active, not recruiting

Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy

Multiple Myeloma

United States
University of Michigan Rogel Cancer Center
Bristol-Myers Squibb; Ipsen

Active, not recruiting

Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

Biliary Tract Cancer

United States
University of Michigan Rogel Cancer Center
American Cancer Society, Inc.

Completed

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

Pain

United States
University of Michigan Rogel Cancer Center
Rush University Medical Center

Completed

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
University of Michigan Rogel Cancer Center
Eli Lilly and Company

Completed

Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain

Breast Cancer

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

Computer-Based Tailored or Standard Information for Colorectal Cancer Screening

Colorectal Cancer

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (IRB 2000-294)

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Liver Cancer
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia (IRB 1996-0189)

Cervical Cancer | Precancerous/Nonmalignant Condition

United States
University of Michigan Rogel Cancer Center
Eli Lilly and Company

Terminated

Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

Carcinoma of Unknown Primary

United States
Wuerzburg University Hospital
University Hospital Tuebingen; University Hospital Schleswig-Holstein

Recruiting

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome (PreVitaCOV)

Post-COVID-19 Syndrome

Germany
University Hospital Schleswig-Holstein
University of Kiel; UCB Biopharma SRL

Recruiting

Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study (PASS-PD)

Parkinson Disease

Germany
University Hospital Schleswig-Holstein
Fachklinik Hornheide an der Universität Münster

Completed

Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa | Wide Excision

Germany
University Hospital Schleswig-Holstein
German Research Foundation; University Hospital Frankfurt

Terminated

Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study)

Myocardial Injury | Mortality

Germany
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Recruiting

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Colorectal Neoplasia

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Recruiting

Metastatic Leiomyosarcoma Biomarker Protocol

Leiomyosarcoma

United States
University of Michigan Rogel Cancer Center
Pfizer; Acrotech Biopharma Inc.

Recruiting

Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer

Metastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian Carcinoma

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Recruiting

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

Recurrent Glioblastoma | Newly Diagnosed Glioblastoma | Recurrent Gliosarcoma | Recurrent Astrocytoma, Grade IV | Newly Diagnosed Gliosarcoma | Newly Diagnosed Astrocytoma, Grade IV

United States
University of Michigan Rogel Cancer Center
Ascentage Pharma Group Inc.

Active, not recruiting

APG-115 in Salivary Gland Cancer Trial

Salivary Gland Cancer | Malignant Salivary Gland Cancer

United States

Clinical Trials Sponsored by Roger Goldstein

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations